期刊文献+
共找到186篇文章
< 1 2 10 >
每页显示 20 50 100
Infliximab is superior to other biological agents for treatment of active ulcerative colitis:A meta-analysis 被引量:6
1
作者 Wei-Qun Mei Hui-Zhen Hu +2 位作者 Ying Liu Zhi-Chen Li Wei-Guo Wang 《World Journal of Gastroenterology》 SCIE CAS 2015年第19期6044-6051,共8页
AIM: To compare the efficacy and safety of biological agents for the treatment of active ulcerative colitis(UC).METHODS: PubMed, MEDLINE, EMBASE and the Cochrane library were searched to screen relevant articles from ... AIM: To compare the efficacy and safety of biological agents for the treatment of active ulcerative colitis(UC).METHODS: PubMed, MEDLINE, EMBASE and the Cochrane library were searched to screen relevant articles from January 1996 to August 2014. The mixedtreatment comparison meta-analysis within a Bayesian framework was performed using WinBUGS14 software.The proportions of patients reaching clinical response,clinical remission and mucosal healing in induction and maintenance phases were analyzed as efficacy indicators. Serious adverse events in maintenance phase were analyzed as safety indicators.RESULTS: The meta-analysis results showed that biological agents achieved better clinical response,clinical remission and mucosal healing than placebo.Indirect comparison indicated that in induction phase,infliximab was more effective than adalimumab in inducing clinical response(OR = 0.41, 95%CI:0.29-0.57), clinical remission(OR = 0.33, 95%CI:0.19-0.56) and mucosal healing(OR = 0.33, 95%CI:0.19-0.56), and golimumab in inducing clinical response(OR = 0.66, 95%CI: 0.39-2.33) and mucosal healing(OR = 2.15, 95%CI: 1.18-4.22). No significant difference was found between placebo and biological agents regarding their safety.CONCLUSION: All biological agents were superior to placebo for UC treatment in both induction and maintenance phases with a similar safety profile, and infliximab had a better clinical effect than the other biological agents. 展开更多
关键词 Biological agents DRUG safety Efficacy META-ANALYSIS ulcerATIVE COLITIS
下载PDF
Gastrointestinal contrast-enhanced ultrasonography for diagnosis and treatment of peptic ulcer in children
2
作者 Yu-Hua Zhang Zhi-Hua Xu +1 位作者 Shuang-Shuang Ni Hong-Xia Luo 《World Journal of Gastroenterology》 SCIE CAS 2024年第7期705-713,共9页
BACKGROUND The detection rate of peptic ulcer in children is improving,with development of diagnostic procedures.Gastroscopy is the gold standard for the diagnosis of peptic ulcer,but it is an invasive procedure.Gastr... BACKGROUND The detection rate of peptic ulcer in children is improving,with development of diagnostic procedures.Gastroscopy is the gold standard for the diagnosis of peptic ulcer,but it is an invasive procedure.Gastrointestinal contrast-enhanced ultrasonography(CEUS)has the advantages of being painless,noninvasive,nonradioactive,easy to use,and safe.AIM To investigate the clinical value of CEUS for diagnosis and treatment of peptic ulcer in children.METHODS We investigated 43 children with digestive tract symptoms in our hospital from January 2021 to June 2022.All children were examined by routine ultrasound,gastrointestinal CEUS,and gastroscopy.The pathological results of gastroscopy were taken as the gold standard.Routine ultrasonography was performed before gastrointestinal CEUS.Conventional ultrasound showed the thickness of the gastroduodenal wall,gastric peristalsis,and the adjacent organs and tissues around the abdominal cavity.Gastrointestinal CEUS recorded the thickness of the gastroduodenal wall;the size,location and shape of the ulcer;gastric peristalsis;and adjacent organs and tissues around the abdominal cavity.The results of routine ultrasound and gastrointestinal ultrasound were compared with those of gastroscopy to evaluate the diagnostic results and coincidence rate of routine ultrasound and gastrointestinal CEUS.All children received informed consent from their guardians for CEUS.This study was reviewed and approved by the hospital medical ethics committee.RESULTS Among the 43 children,17(15 male,2 female)were diagnosed with peptic ulcer by gastroscopy.There were 26 children with nonpeptic ulcer.There were eight cases of peptic ulcer and 35 of nonpeptic ulcer diagnosed by conventional ultrasound.The diagnostic coincidence rate of peptic ulcer in children diagnosed by conventional ultrasound was 79.1%(34/43),which was significantly different from that of gastroscopy(P=0.033).It indicates that the coincidence rate of gastrointestinal contrast-enhanced ultrasound and gastroscope is low.Fifteen cases of peptic ulcer and 28 of nonpeptic ulcer were diagnosed by CEUS.The diagnostic coincidence rate of peptic ulcer in children was 95.3%(41/43).There was no significant difference between CEUS and gastroscopy(P=0.655).It indicates that the coincidence rate of gastrointestinal contrast-enhanced ultrasound and gastroscope is high.CONCLUSION Gastrointestinal CEUS has a high coincidence rate in the diagnosis of peptic ulcer in children,and can be used as a preliminary examination method. 展开更多
关键词 Contrast-enhanced ultrasound Peptic ulcer CHILDREN Gastrointestinal tract Abdominal pain Acoustic contrast agent
下载PDF
Colitis associated with biological agents 被引量:3
3
作者 Hugh James Freeman 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第16期1871-1874,共4页
In the past,there has been considerable focus on a host of drugs and chemicals that may produce colonic toxicity.Now,a variety of new biological monoclonal antibody agents,usually administered by infusion,have appeare... In the past,there has been considerable focus on a host of drugs and chemicals that may produce colonic toxicity.Now,a variety of new biological monoclonal antibody agents,usually administered by infusion,have appeared in the clinical realm over the last decade or so to treat different chronic inflammatory or malignant disorders.For some of these agents,adverse effects have been documented,including apparently new forms of immune-mediated inflammatory bowel disease.In some,only limited symptoms have been recorded,but in others,severe colitis with serious complications,such as bowel perforation has been recorded.In others,adverse effects may have a direct vascular or ischemic basis,while other intestinal effects may be related to a superimposed infection.Some new onset cases of ulcerative colitis or Crohn's disease may also be attributed to the same agents used to treat these diseases,or be responsible for disease exacerbation.Dramatic and well documented side effects have been observed with ipilimumab,a humanized monoclonal antibody developed to reduce and overcome cytotoxic T-lymphocyte antigen 4,a key negative feedback regulator of the T-cell anti-tumor response.This agent has frequently been used in the treatment of different malignancies,notably,malignant melanoma.Side effects with this agent occur in up to 40% and these are believed to be largely immune-mediated.One of these is a form of enterocolitis that may be severe,and occa-sionally,fatal.Other agents include rituximab(an antiCD20 monoclonal antibody),bevacizumab(a monoclonal antibody against the vascular endothelial growth factor) and anti-tumor necrosis factor agents,including infliximab,adalimumab and etanercept. 展开更多
关键词 溃疡性结肠炎 生物制剂 细胞毒性T淋巴细胞 血管内皮生长因子 单克隆抗体 抗体药物 恶性黑色素瘤 肿瘤坏死因子
下载PDF
Current scenario of traditional medicines in management of diabetic foot ulcers:A review 被引量:5
4
作者 Abhijit S Rayate Basavraj S Nagoba +3 位作者 Sachin S Mumbre Hardi B Mavani Ajay M Gavkare Advait S Deshpande 《World Journal of Diabetes》 SCIE 2023年第1期1-16,共16页
Diabetic foot infections and diabetic foot ulcers(DFU)cause significant suffering and are often recurring.DFU have three important pathogenic factors,namely,microangiopathy causing local tissue anoxia,neuropathy makin... Diabetic foot infections and diabetic foot ulcers(DFU)cause significant suffering and are often recurring.DFU have three important pathogenic factors,namely,microangiopathy causing local tissue anoxia,neuropathy making the foot prone to injuries from trivial trauma,and local tissue hyperglycaemia favouring infection and delaying the wound healing.DFU have been the leading cause for non-traumatic amputations of part or whole of the limb.Western medicines focus mainly on euglycaemia,antimicrobials,debridement and wound cover with grafts,and off-loading techniques.Advances in euglycaemic control,foot care and footwear,systemic antimicrobial therapy,and overall health care access and delivery,have resulted in an overall decrease in amputations.However,the process of wound care after adequate debridement remains a major cost burden globally,especially in developing nations.This process revolves around two basic concerns regarding control/eradication of local infection and promotion of faster healing in a chronic DFU without recurrence.Wound modulation with various dressings and techniques are often a costly affair.Some aspects of the topical therapy with modern/Western medicines are frequently not addressed.Cost of and compliance to these therapies are important as both the wounds and their treatment are“chronic.”Naturally occurring agents/medications from traditional medicine systems have been used frequently in different cultures and nations,though without adequate clinical base/relevance.Traditional Chinese medicine involves restoring yin-yang balance,regulating the‘chi’,and promoting local blood circulation.Traditional medicines from India have been emphasizing on‘naturally’available products to control wound infection and promote all the aspects of wound healing.There is one more group of chemicals which are not pharmaceutical agents but can create acidic milieu in the wound to satisfy the above-mentioned basic concerns.Various natural and plant derived products(e.g.,honey,aloe vera,oils,and calendula)and maggots are also used for wound healing purposes.We believe that patients with a chronic wound are so tired physically,emotionally,and financially that they usually accept native traditional medicine which has the same cultural base,belief,and faith.Many of these products have never been tested in accordance to“evidence-based medicine.”There are usually case reports and experience-based reports about these products.Recently,there have been some trials(in vitro and in vivo)to verify the claims of usage of traditional medicines in management of DFU.Such studies show that these natural products enhance the healing process by controlling infection,stimulating granulation tissue,antimicrobial action,promoting fibroblastic activity and collagen deposition,etc.In this review,we attempt to study and analyse the available literature on results of topical traditional medicines,which are usually advocated in the management of DFU.An integrated and‘holistic’approach of both modern and traditional medicine may be more acceptable to the patient,cost effective,and easy to administer and monitor.This may also nevertheless lead to further improvement in quality of life and decrease in the rates of amputations for DFU. 展开更多
关键词 Diabetic foot infections Diabetic foot ulcers MANAGEMENT Traditional medicines Topical agents Wound healing
下载PDF
溃疡性结肠炎生物制剂的研究现状和热点分析
5
作者 杨二强 乔高星 +2 位作者 卢晓静 楚尧娟 杜书章 《河南医学研究》 CAS 2024年第3期392-400,共9页
目的 分析溃疡性结肠炎(UC)生物制剂的研究现状、热点和发展趋势,为我国UC生物制剂的相关研究提供参考。方法 检索Web of Science核心合集数据库中发表于2013年1月1日至2022年12月31日关于UC生物制剂研究的相关文献,利用文献计量在线分... 目的 分析溃疡性结肠炎(UC)生物制剂的研究现状、热点和发展趋势,为我国UC生物制剂的相关研究提供参考。方法 检索Web of Science核心合集数据库中发表于2013年1月1日至2022年12月31日关于UC生物制剂研究的相关文献,利用文献计量在线分析平台(https://bibliometric.com/)和CiteSpace软件统计分析相关研究的发文量、国家/地区、机构、作者、期刊等文献关键特征。结果 共纳入文献3 928篇,年发文量整体呈逐年增加的趋势;开展该领域研究的国家/地区有109个,美国占领先优势(1 209篇,占总发文量的31.03%),且与其他国家合作密切;参与该领域研究的机构共456个,加州大学圣地亚哥分校的发文量(121篇)和中心度(0.09)均排名首位;发文量最大的作者是法国洛林大学的Peyrin-Biroulet L(101篇),共被引频次排名首位的作者是加州大学圣地亚哥分校的Sandborn W J(1 055次);共计1 012个期刊发表了相关文献,发文量和共被引频次最高的期刊均为Inflammatory Bowel Diseases(267篇,1 376次);共被引频次最高的文献是Ungaro等在2017年发表的综述“Ulcerative colitis”,共被引文献中心度排名首位的是Sandborn等在2017年发表的“Tofacitinib as induction and maintenance therapy for ulcerative colitis”;该领域的研究热点主要集中在生物制剂有效性、治疗药物监测、特殊群体用药、药物经济学评价等方面。结论 我国UC生物制剂的研究与国外相比还存在一定差距,应加强国际合作交流,及时跟进该领域的研究热点和未来发展趋势。 展开更多
关键词 溃疡性结肠炎 生物制剂 研究热点 可视化分析
下载PDF
生物制剂和小分子药物治疗溃疡性结肠炎有效性与安全性的网状Meta分析
6
作者 谭书法 张磊昌 +2 位作者 高强强 欧艳 黄水兰 《中国全科医学》 CAS 北大核心 2024年第17期2155-2166,共12页
背景溃疡性结肠炎(UC)是一种慢性复发和缓解性免疫介导的炎症性肠病,其治疗方式还存在争议,大约一半的患者病程发展复杂,伴有慢性活动或频繁复发的UC症状,严重影响了患者的生活质量。目的目前UC的治疗方式越来越多,本研究旨在比较生物... 背景溃疡性结肠炎(UC)是一种慢性复发和缓解性免疫介导的炎症性肠病,其治疗方式还存在争议,大约一半的患者病程发展复杂,伴有慢性活动或频繁复发的UC症状,严重影响了患者的生活质量。目的目前UC的治疗方式越来越多,本研究旨在比较生物制剂和小分子药物治疗UC患者的相对疗效和安全性。方法2名研究人员独立使用PubMed、Embase、Web of Science、Cochrane Library、中国知网、万方数据知识服务平台、维普网数据库搜索有关生物制剂和小分子药物治疗UC的随机对照试验,干预组为生物制剂或小分子药物,对照组为安慰剂。采用Cochrane偏倚风险工具、RevMan 5.4对纳入研究进行质量评价,采用R Studio进行成对分析和网络荟萃分析,采用累积排序概率图下面积(SUCRA)对各结局指标的纳入药物进行排序,以比较不同治疗方式对UC的临床疗效。结果共纳入25项研究,包括9546例UC患者,10种药物干预方案(Filgotinib 100 mg、Filgotinib 200 mg、Upadacitinib、Tofacitinib、Etrolizumab、Adalimumab、Vedolizumab、Golimumab 50 mg、Golimumab 100 mg、Infliximab)。各药物对临床缓解效果的SUCRA概率排序结果显示,Upadacitinib(94.1%)>Vedolizumab(85.1%)>Tofacitinib(74.3%)>Infliximab(72.7%)>Filgotinib 200 mg(51.5%)>Golimumab 100 mg(44.3%)>Golimumab 50 mg(39.3%)>Etrolizumab(38.9%)>Adalimumab(29.8%)>Filgotinib 100 mg(18.7%)>Placebo(0.7%)。各药物对临床反应效果的SUCRA概率排序结果显示,Upadacitinib(98.4%)>Infliximab(84.4%)>Tofacitinib(67.2%)>Vedolizumab(58.4%)>Golimumab50 mg(53.3%)>Adalimumab(34.6%)>Golimumab 100 mg(30.1%)>Placebo(0.4%)。各药物对内镜缓解效果的SUCRA概率排序结果显示,Upadacitinib(98.7%)>Tofacitinib(68.6%)>Filgotinib 200 mg(59.6%)>Adalimumab(55.2%)>Etrolizumab(46.0%)>Vedolizumab(45.9%)>Filgotinib 100 mg(23.4%)>Placebo(2.2%)。各药物对黏膜愈合效果的SUCRA概率排序结果显示,Upadacitinib(99.7%)>Tofacitinib(77.2%)>Infliximab(65.2%)>Golimumab 50 mg(46.4%)>Vedolizumab(44.4%)>Adalimumab(33.8%)>Golimumab 100 mg(31.9%)>Placebo(1.0%)。各药物不良事件风险的SUCRA概率排序结果显示,Golimumab 100 mg(96.7%)>Golimumab 50 mg(92.1%)>Placebo(68.7%)>Tofacitinib(60.8%)>Adalimumab(60.7%)>Etrolizumab(47.2%)>Upadacitinib(42.2%)>Vedolizumab(41.3%)>Infliximab(27.0%)>Filgotinib 200 mg(6.6%)>Filgotinib 100 mg(6.2%)。结论Upadacitinib在临床反应、临床缓解、黏膜愈合以及内镜缓解方面均展现出最佳效用,在不良事件方面Filgotinib 100 mg表现出更为安全的结果。 展开更多
关键词 溃疡性结肠炎 生物制剂 小分子药物 临床疗效 网状Meta分析
下载PDF
大隐静脉高位结扎联合泡沫硬化剂注射术+外用重组人酸性成纤维细胞生长因子治疗重度静脉曲张合并溃疡患者的临床疗效
7
作者 江榕 何洪青 +2 位作者 陈小彬 林晨 王瑜 《血管与腔内血管外科杂志》 2024年第3期257-261,281,共6页
目的探讨大隐静脉高位结扎联合泡沫硬化剂注射术+外用重组人酸性成纤维细胞生长因子治疗重度静脉曲张合并溃疡患者的临床疗效。方法收集2018年1月至2023年6月解放军联勤保障部队第九〇〇医院收治的60例大隐静脉曲张患者的临床资料,按照... 目的探讨大隐静脉高位结扎联合泡沫硬化剂注射术+外用重组人酸性成纤维细胞生长因子治疗重度静脉曲张合并溃疡患者的临床疗效。方法收集2018年1月至2023年6月解放军联勤保障部队第九〇〇医院收治的60例大隐静脉曲张患者的临床资料,按照治疗方式的不同将其分为对照组(n=30)与观察组(n=30),两组患者均采用大隐静脉高位结扎联合泡沫硬化剂注射术,对照组溃疡创面采用碘伏和生理盐水常规换药,观察组溃疡创面采用外用重组人酸性成纤维细胞生长因子治疗。比较两组患者手术时间、术中出血量、住院时间、住院费用、术后并发症的发生情况、治疗前后溃疡面积、溃疡愈合时间、疼痛数字评价量表(NRS)评分以及患者对诊疗过程的满意度。结果观察组患者住院时间短于对照组患者,差异有统计学意义(P﹤0.05)。术后第7天,两组患者溃疡面积均小于本组术前,且观察组患者溃疡面积小于对照组患者,差异均有统计学意义(P﹤0.05)。观察组患者溃疡愈合时间短于对照组患者,差异有统计学意义(P﹤0.05)。术后第14天,两组患者NRS评分均低于本组术前,且观察组患者NRS评分低于对照组患者,差异均有统计学意义(P﹤0.05)。观察组患者满意度评分高于对照组患者,差异有统计学意义(P﹤0.05)。结论大隐静脉高位结扎联合泡沫硬化剂注射术+外用重组人酸性成纤维细胞生长因子可显著促进下肢静脉性溃疡创面的愈合,明显缩短溃疡愈合时间、住院时间,缓解患者下肢疼痛程度,提高患者的诊疗满意度,值得在临床上进一步推广应用。 展开更多
关键词 大隐静脉曲张 溃疡 泡沫硬化剂注射术 外用重组人酸性成纤维细胞生长因子 高位结扎
下载PDF
Changes of gastric ulcer bleeding in the metropolitan area of Japan 被引量:10
8
作者 Yoko Kubosawa Hideki Mori +6 位作者 Satoshi Kinoshita Yoshihiro Nakazato Ai Fujimoto Masahiro Kikuchi Toshihiro Nishizawa Masayuki Suzuki Hidekazu Suzuki 《World Journal of Gastroenterology》 SCIE CAS 2019年第42期6342-6353,共12页
BACKGROUND The two main causes of gastric ulcer bleeding are Helicobacter pylori(H.pylori)infection and ulcerogenic medicines,although the number of cases caused by each may vary with age.In Japan,the rate of H.pylori... BACKGROUND The two main causes of gastric ulcer bleeding are Helicobacter pylori(H.pylori)infection and ulcerogenic medicines,although the number of cases caused by each may vary with age.In Japan,the rate of H.pylori infection has fallen over the last decade and the number of prescriptions for non-steroidal anti-inflammatory drugs(NSAIDs)and antithrombotic drugs is increasing as the population ages.Methods of treatment for gastric ulcer bleeding have advanced with the advent of hemostatic forceps and potassium-competitive acid blocker(P-CAB).Thus,causes and treatments for gastric ulcer bleeding have changed over the last decade.AIM To examine the trends of gastric ulcer bleeding over 10 years in the metropolitan area of Japan.METHODS This is a single-center retrospective study.A total of 564 patients were enrolled from inpatients admitted to our hospital with gastric ulcer bleeding between 2006 and 2016.Age,medication history,H.pylori infection,method of treatment,rate of rebleeding,and the length of hospitalization were analyzed.Factors associated with gastric ulcer bleeding were evaluated using Fisher’s exact test,Pearson’s Chi-squared test or Student’s t-test as appropriate.The Jonckheere-Terpstra test was used to evaluate trends.A per-protocol analysis was used to examine the rate of H.pylori infection.RESULTS There was a significant increase in the mean age over time(P<0.01).The rate of H.pylori infection tended to decrease over the study period(P=0.10),whereas the proportion of patients taking antithrombotic agents or NSAIDs tended to increase(P=0.07).Over time,the use of NSAIDs and antithrombotic drugs increased with age.By contrast,the rate of H.pylori infection during the study period fell with age.H.pylori-induced ulcers accounted for the majority of cases in younger patients(<70 years old);however,the rate decreased with age(P<0.01).The method of treatment trend has changed significantly over time.The main method of endoscopic hemostasis has changed from clipping and injection to forceps coagulation(P<0.01),and frequently prescribed medicines have changed from proton pump inhibitor to P-CAB(P<0.01).The rate of rebleeding during the latter half of the study was significantly lower than that in the first half.CONCLUSION These trends,gastric ulcers caused by ulcerogenic drugs were increasing with age and H.pylori-induced ulcers were more common in younger patients,were observed. 展开更多
关键词 HELICOBACTER PYLORI infection Gastric ulcer bleeding NON-STEROIDAL ANTIINFLAMMATORY drugs ANTITHROMBOTIC agents
下载PDF
Herpes simplex induced necrotizing tonsillitis in an immunocompromised patient with ulcerative colitis 被引量:1
9
作者 Laura Jansen Xander G Vos Mark L?wenberg 《World Journal of Clinical Cases》 SCIE 2016年第2期60-62,共3页
We here present the case of a 22-year-old female of Suriname ethnicity with ulcerative colitis who received treatment with mercaptopurine and infliximab.She presented herself with a severe necrotizing tonsillitis due ... We here present the case of a 22-year-old female of Suriname ethnicity with ulcerative colitis who received treatment with mercaptopurine and infliximab.She presented herself with a severe necrotizing tonsillitis due to herpes simplex virus type-1(HSV-1).Combination therapy consisting of immunomodulators and anti-tumor necrosis factor(TNF) agents is increasingly being used.Anti-TNF therapy is associated with an increased risk of developing serious infections,and especially patients receiving combination treatment with thiopurines are at an increased risk.We here show that HSV infections can cause a severe tonsillitis in immunocompromised patients.Early recognition is essential when there is no improvement with initial antibiotic therapy within the first 24 to 72 h.HSV infections should be in the differential diagnosis of immunocompromised patients presenting with a necrotizing tonsillitis and can be confirmed by polymerase chain reaction.Early treatment with antiviral agents should be considered especially if antibiotic treatment fails in such patients. 展开更多
关键词 HERPES simplex virus TONSILLITIS ulcerATIVE colitis IMMUNOSUPPRESSION anti-TUMOR necrosis factor agents
下载PDF
Clinical Evidence to Prevent Pressure Ulcer at High Risk Patients: Systematic Review 被引量:1
10
作者 Tahany Al-Niarat Jafar Alasad Alshraideh 《Open Journal of Nursing》 2019年第7期687-696,共10页
Background: Pressure ulcer (PU) has clinical complications for patients, in addition to cost and quality related consequences for healthcare organizations. PU is defined as a pressure injury is localized damage to the... Background: Pressure ulcer (PU) has clinical complications for patients, in addition to cost and quality related consequences for healthcare organizations. PU is defined as a pressure injury is localized damage to the skin and underlying soft tissue usually over a bony prominence or related to a medical or other devices. The estimated prevalence of PUs among 918,621 patients declined from 13.5% in 2006 to 9.3% in 2015. Aim: The objective of this review is to evaluate the effectiveness of dressing and topical agent to prevent pressure ulcer, for hospitalized adults are at risk to develop a pressure ulcer. Methods: The review considered the randomized clinical trial (RCT), quasi pretest-posttest, and descriptive studies published in English. Participants in the studies were adult, aged over 18 years, considered to be a risk to develop PU, have no PU at the onset of the study, and managed at any healthcare setting. The primary outcome measured in the included studies was considered as the incidence of hospital acquired pressure ulcer (HAPU). Results: The review result out of five RCT and three non-RCT studies. Conclusion: The reviewed trials showed low certainty of imprecision. No definite preventive intervention to prevent PU among patients who at risk to develop PU. And the non-RCT studies, the findings indicate significant results of two studies, but due to the methodological context of non-RCT studies, the findings may not be granted to be generalized. The external factors at each study may affect the effectiveness of the intervention. Also, third study showed no significance of the intervention between groups. 展开更多
关键词 Pressure ulcer PREVENTION DRESSING TOPICAL agent
下载PDF
Does the African garden egg offer protection against experimentally induced ulcers?
11
作者 Anosike Chioma Abonyi Obiora Ubaka Chukwuemeka 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2011年第2期163-166,共4页
Objective:To evaluate the possible antiulcer effect of the African garden egg,Solanum aethiopicum(S.aethiopicum)(a domestic vegetable) experimentally in rats.Methods:A methanol extract of the plant fruit was prepared ... Objective:To evaluate the possible antiulcer effect of the African garden egg,Solanum aethiopicum(S.aethiopicum)(a domestic vegetable) experimentally in rats.Methods:A methanol extract of the plant fruit was prepared by maceration.Twenty five overnight fasted rats for each model were divided randomly into five groups of five rats.Groups 1,2,3,4 and 5 received normal saline,extract dose levels of 100,200 and 400 mg/kg and 100mg/kg of ranitidine respectively.All administrations were given orally.For the indomethacin and aspirin models, ulcerogenic agents(indomethacin,50 mg/kg and aspirin 200 mg/kg) were given thirty minutes after extract treatments and animals sacrificed 8 h later.The acidified ethanol model(ethanol 60%+0.1 mol/L HC1) was given 1hr after extract treatment and animals sacrificed 1 h later. Ulcer index was checked and analysed with appropriate statistical tools.Results:Extract of S. aethiopicum showed positive effect on all the models used.It produced higher ulcer inhibition than ranitidine in the indomethacin and acid-ethanol models.All the anti-ulcer effects of the extract at different doses were dose dependent but only in indomethacin model did it produce statistically significant(P【0.05) ulcer reduction in all doses compared to control.Conclusions: Garden egg,a readily cultivated crop vegetable possesses ulcer protective properties against ulcers induced experimentally making it a cheap source of natural anti-ulcer remedy. 展开更多
关键词 AFRICAN GARDEN EGG Methanol extract ulcer ulcerOGENIC agents
下载PDF
Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer 被引量:4
12
作者 Vladimir T.Ivashkin Tatiana L.Lapina +6 位作者 Oksana Yu.Bondarenko Olga A. Sklanskaya Petr Va.Grigoriev Yuri V.Vasiliev Emilia P.Yakovenko Pavel V.Gulyaev Valeri I.Fedchenko 《World Journal of Gastroenterology》 SCIE CAS CSCD 2002年第5期879-882,共4页
AIM:To assess and compare the efficacy and safety of two triple regimes:A)metronidazole,amoxicillin and omeprazole,which is still widely used in Russia,andB)azithromycin amoxicillin and omeprazole in healing active d... AIM:To assess and compare the efficacy and safety of two triple regimes:A)metronidazole,amoxicillin and omeprazole,which is still widely used in Russia,andB)azithromycin amoxicillin and omeprazole in healing active duodenal ulcer and H.pylori eradication.METHODS:100 patients with active duodenal ulcer were includid in the open,multicentre,randomized study with comparative groups.Patients were randomly assigned to one of the following one-week triple regimes:A)metronidazole500mg bid,amoxicillin1gbid and omeprazole 20mg bid(OAM,n=50)andB)azithromycin1g od for the first3days(total dose3g).amoxicillin 1g bid and first 3days(total dose3g).amoxicillin 1g bid and omeprazole20mg bid(OAA,n=50).Omeprazole 20mg od was given after the eradication course as a monotherapy for three weeks ,The control endoscopy was performed8 weeks after the entry,H.pyloriinfection was determined in the entry of the study and four weeks after the cessation of treatment by means of histology and CLO-test.RESULTS:97 patients completed the study according to the protocol(1patient of the OAM group did not come to the control endoscopy.2patients of the OAA group stopped the treatment because of mild allergic urticaria).Duodenal ulcers were healed in48patients of the OAM group(96%;CI90.5-100%)and in 46patients of the OAAgroup(92%;CI89.5-94.5%)(p=ns).H.pylori infection was eradicated in 15out of 50patients with OAM(30%;CI17-43%)and in36out of 50patients treated with OAA(72%,CI59-85%)(P<0.001)-IПanalysis.CONCLUSION:The triple therapy with omeprazole,amoxicillin and metronidazole failed to eradicateH.pylori in the majorty of patients,which is an essential argument to withdraw this regimen out of the national recommendations,Macrolide with amoxicillin are preferable to achieve higher eradication rates.Azitromycin(1g od for the first3days)can be considered as a successful component of the triple PPI-based regimen. 展开更多
关键词 三联疗法 阿奇霉素 急性十二指肠溃疡 幽门螺杆菌 根除性治疗
下载PDF
CLINICAL STUDY ON 118 CASES OF ULCERATIVE COLITIS TREATED BY INTEGRATION OF TRADITIONAL CHINESE AND WESTERN MEDICINE 被引量:3
13
作者 陈全寿 张汉臣 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 1999年第3期163-165,共3页
118 cases of ulcerative colitis were treated by integration of traditional Chinese andWestern medicine. Another 86 cases of ulcerative colitis were treated by simple westerndrugs as controls. The therapeutic effects f... 118 cases of ulcerative colitis were treated by integration of traditional Chinese andWestern medicine. Another 86 cases of ulcerative colitis were treated by simple westerndrugs as controls. The therapeutic effects for both groups were observed and comparedafter two therapeutic courses of 40 consecutive days. As a result, 39 cases were cured, 60cases improved and 19 cases failed, with a total effective rate of 84% in the treatmentgroup; in the control group, 15 cases were cured, 37 cases improved and 34 cases failed,with a total effective rate of 60.5%. Statistically, the difference was very significant(P【0.01). It can be concluded that treatment of ulcerative colitis by the integrated methodis superior to that by simple western drugs. 展开更多
关键词 溃疡性结肠炎 内科学 中药学 戴裕光 出版社 主编 上海 卫生 愈溃汤 高唱
下载PDF
Perforated duodenal ulcer secondary to deferasirox use in a child successfully managed with laparoscopic drainage:A case report
14
作者 Abdullah Alshehri Tuqa Adil Alsinan 《World Journal of Clinical Cases》 SCIE 2022年第34期12775-12780,共6页
BACKGROUND A perforated gastroduodenal ulcer is rarely observed in children.Certain medications have been reported to cause ulcerations.Deferasirox,an iron chelating agent,has been previously reported to be associated... BACKGROUND A perforated gastroduodenal ulcer is rarely observed in children.Certain medications have been reported to cause ulcerations.Deferasirox,an iron chelating agent,has been previously reported to be associated with the development of gastroduodenal ulcers.CASE SUMMARY We report a case of a 3-year-old boy who was diagnosed with beta thalassemia major and treated with deferasirox.He presented to the emergency department with an acute abdomen.A perforated duodenal ulcer was suspected after X-ray imaging and laparoscopic exploration.It was successfully managed with laparoscopic washout and drainage.CONCLUSION Due to the rarity and severity of this case,it is a reminder that prevention and early recognition of gastrointestinal complications in patients receiving deferasirox are crucial.Minimally invasive laparoscopic surgery is both safe and feasible to treat perforated duodenal ulcers in selected patients. 展开更多
关键词 Peptic ulcer Iron chelating agents DEFERASIROX HEMOGLOBINOPATHIES CHILDREN Case report
下载PDF
小分子制剂在炎症性肠病中的临床应用:现状与未来
15
作者 毛靖伟 《世界华人消化杂志》 CAS 2023年第22期913-921,共9页
炎症性肠病(inflammatory bowel disease,IBD)主要包括溃疡性结肠炎和克罗恩病,属于慢性非特异性肠道炎症性疾病,其病程长、病情反复,发展至后期可增加手术、致残风险,降低患者生活质量、加重家庭及社会经济负担.目前认为遗传、免疫、... 炎症性肠病(inflammatory bowel disease,IBD)主要包括溃疡性结肠炎和克罗恩病,属于慢性非特异性肠道炎症性疾病,其病程长、病情反复,发展至后期可增加手术、致残风险,降低患者生活质量、加重家庭及社会经济负担.目前认为遗传、免疫、肠道菌群及环境等因素均参与了疾病的发生与发展.近年来,该病在我国的发病率逐步升高,由于传统药物如5-氨基水杨酸、皮质类固醇、免疫抑制剂等疗效不足及副作用,使得一部分IBD患者的病情未能得到有效控制.在生物制剂方面,作为靶向治疗“开山者”的抗肿瘤坏死因子(tumor necrosis factor,TNF)拮抗剂应用持续时间最长、范围最为广泛,但数十年的应用数据统计显示其原发、继发失应答的人群比例较为显著.因此,新型靶向治疗药物譬如小分子制剂的不断问世,为传统治疗效果不佳及抗TNF治疗失败的人群开辟了新的道路,但小分子制剂作为一线治疗的定位亦需进一步探索研究.该文主要总结归纳近期临床试验中小分子制剂在IBD治疗中的有效性和安全性,分析其对传统生物制剂尤其是抗TNF治疗原发、继发失应答或不耐受人群的应答、缓解疗效,进行治疗决策的探索,以期探索后续理想的接续治疗药物,指导选择合适的一线靶向治疗药物. 展开更多
关键词 炎症性肠病 溃疡性结肠炎 克罗恩病 小分子制剂
下载PDF
微生态制剂辅助标准四联疗法治疗Hp阳性胃溃疡的效果及对血清学指标、黏膜愈合质量的影响
16
作者 杨蕾 陈莹 《临床医学研究与实践》 2023年第13期49-52,共4页
目的分析微生态制剂辅助标准四联疗法治疗幽门螺杆菌(Hp)阳性胃溃疡的效果及对血清学指标、黏膜愈合质量的影响。方法选择2020年1月至2021年4月收治的130例Hp阳性胃溃疡患者为研究对象,随机将其分为对照组和观察组,各65例。对照组采用... 目的分析微生态制剂辅助标准四联疗法治疗幽门螺杆菌(Hp)阳性胃溃疡的效果及对血清学指标、黏膜愈合质量的影响。方法选择2020年1月至2021年4月收治的130例Hp阳性胃溃疡患者为研究对象,随机将其分为对照组和观察组,各65例。对照组采用标准四联疗法(质子泵抑制剂+2种抗生素+铋剂)治疗,观察组在标准四联疗法基础上给予微生态制剂(双歧杆菌乳杆菌三联活菌片)治疗。比较两组的临床疗效、Hp转阴率、炎症因子、胃肠激素水平及黏膜愈合质量。结果观察组的治疗总有效率和Hp转阴率高于对照组,差异具有统计学意义(P<0.05)。治疗前,两组的白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)及基质金属蛋白酶-9(MMP-9)水平比较,差异无统计学意义(P>0.05);治疗后,两组的IL-6、IL-8、TNF-α及MMP-9水平均较治疗前降低,且观察组低于对照组,差异具有统计学意义(P<0.05)。治疗前,两组的胃泌素(GAS)、胃动素(MTL)、胃蛋白酶原Ⅰ(PGⅠ)及胃蛋白酶原Ⅱ(PGⅡ)水平比较,差异无统计学意义(P>0.05);治疗后,两组的GAS、MTL、PGⅠ及PGⅡ水平均较治疗前降低,且观察组低于对照组,差异具有统计学意义(P<0.05)。治疗前,两组的胶原纤维沉积面积、Ⅰ型/Ⅲ型胶原蛋白比值及羟脯氨酸水平比较,差异无统计学意义(P>0.05);治疗后,观察组的胶原纤维沉积面积、Ⅰ型/Ⅲ型胶原蛋白比值及羟脯氨酸水平高于对照组,差异具有统计学意义(P<0.05)。结论微生态制剂辅助标准四联疗法治疗Hp阳性胃溃疡的效果显著,可提高Hp转阴率,减轻炎症反应,改善胃肠激素水平,提升黏膜愈合质量,值得临床应用。 展开更多
关键词 胃溃疡 幽门螺杆菌 微生态制剂 标准四联疗法 炎症因子 胃肠激素 黏膜愈合质量
下载PDF
生物制剂对炎症性肠病肠外表现作用的研究进展 被引量:2
17
作者 李蕾 朱庆顺 +2 位作者 贺涛 朱玲玉 孙善明 《安徽医药》 CAS 2023年第4期648-652,共5页
炎症性肠病(IBD)临床表现包括腹痛、腹泻、黏液脓血便,不容忽视的是炎症性肠病病人中肠外表现(EIMs)同样影响着疾病的预后与转归。EIMs可以被定义为在各因素驱动肠道炎症过程中,可同时引起的一系列其他器官的炎症,其发病部位位于肠外。E... 炎症性肠病(IBD)临床表现包括腹痛、腹泻、黏液脓血便,不容忽视的是炎症性肠病病人中肠外表现(EIMs)同样影响着疾病的预后与转归。EIMs可以被定义为在各因素驱动肠道炎症过程中,可同时引起的一系列其他器官的炎症,其发病部位位于肠外。EIMs的发生较为少见,目前尚未确定EIMs是肠道炎症延伸的直接结果,还是机体由于遗传因素对环境因素产生的独立的免疫失调反应。一般来说,这两种机制可同时存在,其在不同EIMs中发挥不同程度的作用。目前尚未得出EIMs的明确诊断标准,关于EIMs的管理及治疗也缺少前瞻性研究,仅国外发表了相关的案例分析,国内关于肠外表现的资料尚缺。有研究显示生物制剂使EIMs的治疗成为可能,目前常用生物制剂包括英夫利西单抗、阿达木单抗、维得利珠单抗、戈利木单抗及乌司奴单抗。阅读分析国内外相关的文献,就治疗炎症性肠病的生物制剂对肠外表现的作用作一综述。 展开更多
关键词 炎性肠疾病 溃疡性结肠炎 克罗恩病 肠外表现 生物制剂
下载PDF
复方黄柏液涂剂外敷联合泡沫硬化治疗下肢静脉曲张性溃疡疗效及其对TNF-α、IL-6、CRP水平的影响 被引量:1
18
作者 靳立强 郭海涛 韩书明 《中华中医药学刊》 CAS 北大核心 2023年第11期250-253,共4页
目的分析复方黄柏液涂剂外敷联合泡沫硬化剂治疗下肢静脉曲张性溃疡的临床疗效及其对患者肿瘤坏死因子-α(Tumor necrosis factor-α,TNF-α)、白细胞介素-6(Interleukin-6,IL-6)、C反应蛋白(C-reactive protein,CRP)水平的影响。方法选... 目的分析复方黄柏液涂剂外敷联合泡沫硬化剂治疗下肢静脉曲张性溃疡的临床疗效及其对患者肿瘤坏死因子-α(Tumor necrosis factor-α,TNF-α)、白细胞介素-6(Interleukin-6,IL-6)、C反应蛋白(C-reactive protein,CRP)水平的影响。方法选取2020年1月—2022年1月收治的122例下肢静脉曲张性溃疡患者作为研究对象。按随机数字表法分为两组,观察组61例,采用复方黄柏液涂剂外敷联合泡沫硬化剂治疗,对照组61例,采用泡沫硬化剂注射治疗。统计分析两组临床疗效、治疗前后TNF-α、IL-6、CRP、疼痛视觉模拟评分法(VAS)评分、静脉临床严重程度评分(VCSS)及并发症数据。结果观察组临床总有效率为93.44%(57/61),明显高于对照组的78.69%(48/61),相比差异有统计学意义(χ^(2)=4.200,P=0.040);两组治疗1个月后血清TNF-α、IL-6及CRP水平均明显下降(P<0.001),观察组治疗1个月后血清TNF-α、IL-6及CRP水平显著低于对照组,相比差异有统计学意义(P<0.001);两组治疗1个月后VAS评分及VCSS评分均明显降低(P<0.01),观察组治疗1个月后VAS评分及VCSS评分显著低于对照组,相比差异有统计学意义(P<0.01);观察组并发症总发生率为6.56%,低于对照组的16.39%,相比差异无统计学意义(χ^(2)=2.311,P=0.128)。结论复方黄柏液涂剂外敷联合泡沫硬化剂治疗下肢静脉曲张性溃疡,能够有效抑制炎症因子表达,降低静脉临床严重程度评分,减轻疼痛,提高临床疗效,并发症少,能够兼顾安全性与有效性,值得临床予以推广应用。 展开更多
关键词 下肢静脉曲张性溃疡 复方黄柏液涂剂 泡沫硬化剂 临床疗效 炎症因子
下载PDF
新型黏膜保护剂聚普瑞锌临床应用专家共识
19
作者 中华消化心身联盟 陈胜良 许平 《胃肠病学》 北大核心 2023年第2期82-90,共9页
胃黏膜损伤的类型和修复结局是备受关注的临床热点问题。以促进胃黏膜结构和功能修复为主要治疗目的,或兼有对抗黏膜表面损伤因子、改善黏膜防御机制作用的药物统称为胃黏膜保护剂。聚普瑞锌作为新一代黏膜保护剂,在化学成分、药代动力... 胃黏膜损伤的类型和修复结局是备受关注的临床热点问题。以促进胃黏膜结构和功能修复为主要治疗目的,或兼有对抗黏膜表面损伤因子、改善黏膜防御机制作用的药物统称为胃黏膜保护剂。聚普瑞锌作为新一代黏膜保护剂,在化学成分、药代动力学、作用机制等方面与其他同类药物存在明显差异,在临床使用的适应证、潜在不良反应等方面亦有其独特性。该药在中国内地地区新近准入,在临床合理应用方面尚缺乏我国专家共识意见。中华消化心身联盟组织国内关注消化道黏膜修复临床问题的有关专家,基于国内外研究进展和临床应用经验,就应用黏膜保护剂的必要性、胃黏膜保护剂的个体化选择应用要点,以及聚普瑞锌的药代动力学特点、作用机制和临床应用达成共识意见,为聚普瑞锌在消化道黏膜保护中的合理应用提供参考依据。 展开更多
关键词 胃黏膜损伤 黏膜保护剂 聚普瑞锌 消化性溃疡 幽门螺杆菌
下载PDF
中重度溃疡性结肠炎的生物制剂治疗与手术治疗研究进展 被引量:2
20
作者 陈玉洁(综述) 郭志国(审校) 《海南医学》 CAS 2023年第9期1357-1360,共4页
溃疡性结肠炎(ulcerative colitis,UC)是一种慢性炎症性肠道疾病,可累及结肠的任何部位,从直肠黏膜炎症开始,并持续向近端延伸。其中急性重度UC发生危及生命的并发症导致紧急结肠切除术的风险增加,常需使用免疫调节剂或生物制剂治疗,包... 溃疡性结肠炎(ulcerative colitis,UC)是一种慢性炎症性肠道疾病,可累及结肠的任何部位,从直肠黏膜炎症开始,并持续向近端延伸。其中急性重度UC发生危及生命的并发症导致紧急结肠切除术的风险增加,常需使用免疫调节剂或生物制剂治疗,包括环孢素、TNF-α拮抗剂、维得利珠单抗、乌司奴单抗及Janus激酶(JAK)抑制剂等,以减轻手术风险。中重度UC最佳治疗策略的选择是复杂的,对于不同治疗方法的疗效和安全性的比较临床数据有限,导致实践中存在相当大的差异。因此本文目的是回顾最新临床文献,以阐述中重度UC的治疗策略和决策影响因素。 展开更多
关键词 中重度溃疡性结肠炎 生物制剂 JAK抑制剂 手术 内外科疗法
下载PDF
上一页 1 2 10 下一页 到第
使用帮助 返回顶部